Correlation Between Nuvalent and Tarsus Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nuvalent and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvalent and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvalent and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Nuvalent and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvalent with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvalent and Tarsus Pharmaceuticals.

Diversification Opportunities for Nuvalent and Tarsus Pharmaceuticals

-0.13
  Correlation Coefficient

Good diversification

The 3 months correlation between Nuvalent and Tarsus is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Nuvalent and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Nuvalent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvalent are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Nuvalent i.e., Nuvalent and Tarsus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Nuvalent and Tarsus Pharmaceuticals

Given the investment horizon of 90 days Nuvalent is expected to generate 2.6 times less return on investment than Tarsus Pharmaceuticals. But when comparing it to its historical volatility, Nuvalent is 1.23 times less risky than Tarsus Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Tarsus Pharmaceuticals is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  4,652  in Tarsus Pharmaceuticals on November 18, 2024 and sell it today you would earn a total of  370.00  from holding Tarsus Pharmaceuticals or generate 7.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Nuvalent  vs.  Tarsus Pharmaceuticals

 Performance 
       Timeline  
Nuvalent 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Nuvalent has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.
Tarsus Pharmaceuticals 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Nuvalent and Tarsus Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nuvalent and Tarsus Pharmaceuticals

The main advantage of trading using opposite Nuvalent and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvalent position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.
The idea behind Nuvalent and Tarsus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Money Managers
Screen money managers from public funds and ETFs managed around the world
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments